5 Sexy Ways To Improve Your Xarelto Lawsuit

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably safe for use - and failure to do so could be grounds for compensation. Our lawyers are working difficult to obtain these hurt by the drug the compensation they may be entitled to.

While bleeding can be a widespread complication linked with anticoagulants, it has been alleged that Xarelto is far more harmful than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, inside the event of an emergency, individuals might be at danger for irreversible bleeding troubles, which includes life-threatening internal and gastrointestinal hemorrhaging.

In the event you or possibly a loved a single suffered a critical bleeding occasion following taking Xarelto, you might have legal recourse. For more info, speak to us nowadays to possess your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future health-related bills, lost wages, discomfort and suffering and, in instances of death, funeral costs. In addition, they're seeking punitive damages, which are generally awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of xarelto and inr were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for a lot more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.